# Ketamine Infusion for Sickle Cell Pain Crisis

> **NCT04005209** · PHASE4 · WITHDRAWN · sponsor: **Duke University**

## Conditions studied

- Anemia; Sickle-Cell, With Crisis
- Acute Pain

## Interventions

- **DRUG:** Ketamine
- **OTHER:** Pain management

## Key facts

- **NCT ID:** NCT04005209
- **Lead sponsor:** Duke University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2022-01
- **Primary completion:** 2022-11
- **Final completion:** 2022-11
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Decided not to open study
- **Last updated:** 2022-01-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04005209

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04005209, "Ketamine Infusion for Sickle Cell Pain Crisis". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT04005209. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*